(Q45750778)

15 December 2017

title

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice (English)

1 reference

15 December 2017

0 references

0 references

3

1 reference

15 December 2017

author name string

Berglund P

series ordinal

1

1 reference

15 December 2017

Fleeton MN

series ordinal

2

1 reference

15 December 2017

Liljeström P

series ordinal

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

17

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

497-507

1 reference

15 December 2017

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Recombinant fowlpox virus inducing protective immunity in non-avian species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Self-replicating Semliki Forest virus RNA as recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Neurogenic spread of Semliki Forest virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Selective differentiation of CD4+ T helper cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Expression of IFN A genes in subpopulations of peripheral blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Gamma Interferon Production and Cytotoxicity of Spleen Cells from Mice Infected with Semliki Forest Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900224-2

7 January 2021

10.1016/S0264-410X(98)00224-2

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017